1. Pink Sheet
  2. >>Biosimilars & Generics
  3. >>Generics

One Year On, US FDA Generic Drug Cluster Focuses On Facilitating Collaboration

Group Has Made Significant Progress Regarding Data Sharing

 
• By Chloe Kent

Following its inaugural year, the FDA’s Generic Drug Cluster has formed data sharing arrangements concerning a number of vital indications.

Wooden figures of people gathered around green globe
Several initiatives in the off-patent industry are now focused on regulatory harmonization • Source: Shutterstock

The US Food and Drug Administration’s Generic Drug Cluster has facilitated the gathering and combining of data in several key indications during its first year in operation, a progress report has revealed.

The group said the discussions it has had over the last year “promoted an understanding of approval basis focusing on...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Biosimilars & Generics